AstraZeneca loses major generics appeal in India
The Delhi High Court has cleared the way for a slew of generic diabetes drugs to arrive on the Indian market after it rejected AstraZeneca’s request for a blocking order.
PTAB grants inter partes review of China’s firm’s Alzheimer’s patent
The US Patent Trial and Appeal Board has given the go-ahead for an inter partes review of a Chinese pharma company’s US patent related to a treatment for Alzheimer’s.
Cannabis awards organisers locked in TM suit
A Cannabis industry event company has filed a counterclaim suit to invalidate trademarks held by a competitor, who has accused them of unfair competition.
PTAB invalidates Medytox Botox patent
The Patent Trial and Appeal Board has ruled that a Medytox patent for its wrinkle treatment should not have been granted.
Nevada judge overrules objections in patent disclosure suit
A Nevada federal court judge has overruled objections to a previous ruling on a dispute between investors and cannabidiol company CV Sciences.
Barnes & Thornburg adds life science talent to its Boston IP practice
Barnes & Thornburg has added three new life science IP lawyers to the firm’s new Boston office.
CMA fines drugmakers £260m for 10,000% price hike
The UK’s Competition and Markets Authority has imposed fines of £260 million on drug companies for raising the price of life-saving hydrocortisone tablets by 10,000%.
Novartis accused of owing $47m in IP royalties
Novartis should pay a Daiichi Sankyo subsidiary, Plexxikon, $47 million in overdue IP royalties, according to an argument presented before a federal court in California this week.
Sacha Baron Cohen sues cannabis company for copyright infringement
Actor and comedian Sacha Baron Cohen is suing a US medical cannabis company for its use of his controversial Borat character on a billboard advertisement without his authorisation.
English court says Roche did not infringe insulin pump patents
The English High Court has cleared Roche of patent infringement claims over its line of insulin pumps but shot down the pharma giant’s attempt to invalidate the plaintiff’s patent.
